Trifecta Capital Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1962615 NORTHBROOK, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$404,540

-$40,050 QoQ

Shares Held

3,202

+0.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,486

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $49,578,365 across 11 Drug Manufacturers - General names. GILD ranks #6 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,670	$30,789,370
2	ABBV	AbbVie Inc.	41,305	$10,393,990
3	AMGN	Amgen Inc	16,502	$5,975,704
4	JNJ	Johnson & Johnson	3,836	$974,228
5	MRK	Merck & Co., Inc.	5,740	$737,590
6	GILD	Gilead Sciences, Inc. This page	3,202	$404,540
7	NVO	Novo Nordisk A S	4,016	$192,527
8	PFE	Pfizer Inc	4,277	$102,990

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$404,540	3,202	+0.4%	Shares	Sole	2026-08-03
2026-03-31	$444,590	3,190	+6.3%	Shares	Sole	2026-05-01
2025-12-31	$368,220	3,000	-2.0%	Shares	Sole	2026-01-30
2025-09-30	$339,660	3,060	0.0%	Shares	Sole	2025-11-03
2025-06-30	$339,262	3,060	+766.9%	Shares	Sole	2025-07-23
2025-03-31	$39,553	353	+13.9%	Shares	Sole	2025-04-21
2024-12-31	$28,634	310	0.0%	Shares	Sole	2025-02-04
2024-09-30	$25,990	310	0.0%	Shares	Sole	2024-10-16
2024-06-30	$21,269	310	0.0%	Shares	Sole	2024-08-07
2024-03-31	$22,707	310	0.0%	Shares	Sole	2024-04-16
2023-12-31	$25,113	310	0.0%	Shares	Sole	2024-01-25
2023-09-30	$23,231	310	-95.8%	Shares	Sole	2023-11-01
2023-06-30	$570,086	7,397	-5.5%	Shares	Sole	2023-08-14
2023-03-31	$649,240	7,825	-2.7%	Shares	Sole	2023-05-09
2022-12-31	$690,663	8,045	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.